Scientific Advances in Thoracic Oncology 2016

Ross A. Soo; Emily C.A. Stone; K. Michael Cummings; James R. Jett; John K. Field; Harry J.M. Groen; James L. Mulshine; Yasushi Yatabe; Lukas Bubendorf; Sanja Dacic; Ramon Rami-Porta; Frank C. Detterbeck; Eric Lim; Hisao Asamura; Jessica Donington; Heather A. Wakelee; Yi Long Wu; Kristin Higgins; Suresh Senan; Benjamin Solomon; Dong Wan Kim; Melissa Johnson; James C.H. Yang; Lecia V. Sequist; Alice T. Shaw; Myung Ju Ahn; Daniel B. Costa; Jyoti D. Patel; Leora Horn; Scott Gettinger; Solange Peters; Murry W. Wynes; Corinne Faivre-Finn; Charles M. Rudin; Anne Tsao; Paul Baas; Ronan J. Kelly; Natasha B. Leighl; Giorgio V. Scagliotti; David R. Gandara; Fred R. Hirsch; David R. Spigel

doi:10.1016/j.jtho.2017.05.019

Scientific Advances in Thoracic Oncology 2016

Ross A. Soo
, Emily C.A. Stone
, K. Michael Cummings
, James R. Jett
, John K. Field
, Harry J.M. Groen
, James L. Mulshine
, Yasushi Yatabe
, Lukas Bubendorf
, Sanja Dacic
, Ramon Rami-Porta
, Frank C. Detterbeck
, Eric Lim
, Hisao Asamura
, Jessica Donington
, Heather A. Wakelee
, Yi Long Wu
, Kristin Higgins
, Suresh Senan
, Benjamin Solomon

Dong Wan Kim, Melissa Johnson, James C.H. Yang, Lecia V. Sequist, Alice T. Shaw, Myung Ju Ahn, Daniel B. Costa, Jyoti D. Patel, Leora Horn, Scott Gettinger, Solange Peters, Murry W. Wynes, Corinne Faivre-Finn, Charles M. Rudin, Anne Tsao, Paul Baas, Ronan J. Kelly, Natasha B. Leighl, Giorgio V. Scagliotti, David R. Gandara, Fred R. Hirsch, David R. Spigel

外科学(呼吸器)

研究成果: Review article › 査読

50 被引用数 (Scopus)

抄録

Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

本文言語	English
ページ（範囲）	1183-1209
ページ数	27
ジャーナル	Journal of Thoracic Oncology
巻	12
号	8
DOI	https://doi.org/10.1016/j.jtho.2017.05.019
出版ステータス	Published - 2017 8月

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

腫瘍学
呼吸器内科

文献へのアクセス

10.1016/j.jtho.2017.05.019

他のファイルとリンク

引用スタイル

Soo, R. A., Stone, E. C. A., Cummings, K. M., Jett, J. R., Field, J. K., Groen, H. J. M., Mulshine, J. L., Yatabe, Y., Bubendorf, L., Dacic, S., Rami-Porta, R., Detterbeck, F. C., Lim, E., Asamura, H., Donington, J., Wakelee, H. A., Wu, Y. L., Higgins, K., Senan, S., ... Spigel, D. R. (2017). Scientific Advances in Thoracic Oncology 2016. Journal of Thoracic Oncology, 12(8), 1183-1209. https://doi.org/10.1016/j.jtho.2017.05.019

Soo, RA, Stone, ECA, Cummings, KM, Jett, JR, Field, JK, Groen, HJM, Mulshine, JL, Yatabe, Y, Bubendorf, L, Dacic, S, Rami-Porta, R, Detterbeck, FC, Lim, E, Asamura, H, Donington, J, Wakelee, HA, Wu, YL, Higgins, K, Senan, S, Solomon, B, Kim, DW, Johnson, M, Yang, JCH, Sequist, LV, Shaw, AT, Ahn, MJ, Costa, DB, Patel, JD, Horn, L, Gettinger, S, Peters, S, Wynes, MW, Faivre-Finn, C, Rudin, CM, Tsao, A, Baas, P, Kelly, RJ, Leighl, NB, Scagliotti, GV, Gandara, DR, Hirsch, FR & Spigel, DR 2017, 'Scientific Advances in Thoracic Oncology 2016', Journal of Thoracic Oncology, vol. 12, no. 8, pp. 1183-1209. https://doi.org/10.1016/j.jtho.2017.05.019

@article{5016695698b9492b9767eebee81c20de,

title = "Scientific Advances in Thoracic Oncology 2016",

abstract = "Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.",

keywords = "Adjuvant therapy, Biomarkers, Cancer prevention, Immunotherapy, Malignant mesothelioma, Molecular diagnostics, NSCLC, Pathology, Radiotherapy, SCLC, Screening, Smoking cessation, Staging, Surgery, Targeted therapy, Value of therapy",

author = "Soo, \{Ross A.\} and Stone, \{Emily C.A.\} and Cummings, \{K. Michael\} and Jett, \{James R.\} and Field, \{John K.\} and Groen, \{Harry J.M.\} and Mulshine, \{James L.\} and Yasushi Yatabe and Lukas Bubendorf and Sanja Dacic and Ramon Rami-Porta and Detterbeck, \{Frank C.\} and Eric Lim and Hisao Asamura and Jessica Donington and Wakelee, \{Heather A.\} and Wu, \{Yi Long\} and Kristin Higgins and Suresh Senan and Benjamin Solomon and Kim, \{Dong Wan\} and Melissa Johnson and Yang, \{James C.H.\} and Sequist, \{Lecia V.\} and Shaw, \{Alice T.\} and Ahn, \{Myung Ju\} and Costa, \{Daniel B.\} and Patel, \{Jyoti D.\} and Leora Horn and Scott Gettinger and Solange Peters and Wynes, \{Murry W.\} and Corinne Faivre-Finn and Rudin, \{Charles M.\} and Anne Tsao and Paul Baas and Kelly, \{Ronan J.\} and Leighl, \{Natasha B.\} and Scagliotti, \{Giorgio V.\} and Gandara, \{David R.\} and Hirsch, \{Fred R.\} and Spigel, \{David R.\}",

note = "Publisher Copyright: {\textcopyright} 2017 International Association for the Study of Lung Cancer",

year = "2017",

month = aug,

doi = "10.1016/j.jtho.2017.05.019",

language = "English",

volume = "12",

pages = "1183--1209",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "8",

}

TY - JOUR

T1 - Scientific Advances in Thoracic Oncology 2016

AU - Soo, Ross A.

AU - Stone, Emily C.A.

AU - Cummings, K. Michael

AU - Jett, James R.

AU - Field, John K.

AU - Groen, Harry J.M.

AU - Mulshine, James L.

AU - Yatabe, Yasushi

AU - Bubendorf, Lukas

AU - Dacic, Sanja

AU - Rami-Porta, Ramon

AU - Detterbeck, Frank C.

AU - Lim, Eric

AU - Asamura, Hisao

AU - Donington, Jessica

AU - Wakelee, Heather A.

AU - Wu, Yi Long

AU - Higgins, Kristin

AU - Senan, Suresh

AU - Solomon, Benjamin

AU - Kim, Dong Wan

AU - Johnson, Melissa

AU - Yang, James C.H.

AU - Sequist, Lecia V.

AU - Shaw, Alice T.

AU - Ahn, Myung Ju

AU - Costa, Daniel B.

AU - Patel, Jyoti D.

AU - Horn, Leora

AU - Gettinger, Scott

AU - Peters, Solange

AU - Wynes, Murry W.

AU - Faivre-Finn, Corinne

AU - Rudin, Charles M.

AU - Tsao, Anne

AU - Baas, Paul

AU - Kelly, Ronan J.

AU - Leighl, Natasha B.

AU - Scagliotti, Giorgio V.

AU - Gandara, David R.

AU - Hirsch, Fred R.

AU - Spigel, David R.

PY - 2017/8

Y1 - 2017/8

N2 - Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

AB - Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

KW - Adjuvant therapy

KW - Biomarkers

KW - Cancer prevention

KW - Immunotherapy

KW - Malignant mesothelioma

KW - Molecular diagnostics

KW - NSCLC

KW - Pathology

KW - Radiotherapy

KW - SCLC

KW - Screening

KW - Smoking cessation

KW - Staging

KW - Surgery

KW - Targeted therapy

KW - Value of therapy

UR - https://www.scopus.com/pages/publications/85030094918

UR - https://www.scopus.com/pages/publications/85030094918#tab=citedBy

U2 - 10.1016/j.jtho.2017.05.019

DO - 10.1016/j.jtho.2017.05.019

M3 - Review article

C2 - 28579481

AN - SCOPUS:85030094918

SN - 1556-0864

VL - 12

SP - 1183

EP - 1209

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 8

ER -

Scientific Advances in Thoracic Oncology 2016

抄録

UN SDG

ASJC Scopus subject areas

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル